title: Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
authors.affiliation: Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
authors.forename: Eunyoung
authors.initials: E
authors.lastname: Lee
authors.forename: Tae Min
authors.initials: TM
authors.lastname: Kim
authors.forename: Yoojoo
authors.initials: Y
authors.lastname: Lim
authors.forename: Yoon Kyung
authors.initials: YK
authors.lastname: Jeon
authors.forename: Heounjeong
authors.initials: H
authors.lastname: Go
authors.forename: Chul Woo
authors.initials: CW
authors.lastname: Kim
authors.forename: Dae Seog
authors.initials: DS
authors.lastname: Heo
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016470:Bacteremia / Q000209:etiology; D017714:Community-Acquired Infections / Q000209:etiology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D018450:Disease Progression; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000473:pathology; D004927:Escherichia coli Infections / Q000150:complications / Q000209:etiology; D017809:Fatal Outcome; D005260:Female; D006562:Herpes Zoster / Q000209:etiology; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology* / Q000821:virology; D008207:Lymphatic Metastasis; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*; D016399:Lymphoma, T-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000821:virology; D009503:Neutropenia / Q000139:chemically induced; D045363:Pneumocystis carinii / Q000302:isolation & purification; D011020:Pneumonia, Pneumocystis / Q000209:etiology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012008:Recurrence; D000069283:Rituximab; D016879:Salvage Therapy; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone